Therapies and Procedures
AtriCure offers a robust portfolio of products used in some of the most complex therapies and procedures.
- Healthcare Professionals
- Patients & Caregivers
- About AtriCure
Hybrid AF Therapy with EPi-Sense System
Minimally Invasive Ablation Therapy for the Treatment of Advanced Atrial Fibrillation
First Patient Treated in HEAL-IST™ Trial
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator Synergy Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia
First Patient Treated in LeAAPS Clinical Trial
Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
Providing Several Months of Post-Operative Pain Relief
Cryo Nerve Block Therapy uses a unique freezing method to temporarily block pain signals from the nerves.
Top Workplaces 2023
Ready to work at a Top Workplace?
We are Humbled by Our Talented Board and Employees!
Our responsibility to advance Diversity, Equity, and Inclusion is driven by a passionate belief that diverse thinking, skills, and experience bring the best outcome to our work as we innovate products and therapies that improve patients’ lives.
0
Patients Served with Ablation Worldwide
0
AtriClip Devices Sold Worldwide
NEWS
AtriCure Reports Second Quarter 2023 Financial Results
REDUCING GLOBAL AFIB
What is Afib, and how does it affect heart performance?
CAREERS
Interested in joining our mission to reduce the global Afib epidemic?
THERAPY INNOVATION
Post-Operative Pain Management: Opening the Door to Some Cool Options
PM-EUMEA-2653A-0525-G
© 2023 Atricure, Inc. All Rights Reserved.
Moderate exercise is known to reduce the risk of Afib, but for middle-aged endurance athletes, it can lead to a 5x increased risk of Afib. To learn more about who this affects, visit https://bit.ly/3PEmYvm #CardioTwitter #afib #Epeeps
Moderate exercise is known to reduce the risk of Afib, but for middle-aged endurance athletes, it can lead to a 5x increased risk of Afib. To learn more about who this affects, visit https://bit.ly/3PEmYvm #CardioTwitter #afib #Epeeps
Join Cardio Thoracic Surgeons, EPs, and Nurses at the 37th EACTS Annual Meeting in Vienna! During EACTS we'll explore AF and HF's close relationship in our Symposium on 5th October. To learn more about AtriCure activities at EACTS, visit https://bit.ly/3rCBDiu #cardiotwitter
Join Cardio Thoracic Surgeons, EPs, and Nurses at the 37th EACTS Annual Meeting in Vienna! During EACTS we'll explore AF and HF's close relationship in our Symposium on 5th October. To learn more about AtriCure activities at EACTS, visit https://bit.ly/3rCBDiu #cardiotwitter
Two is better than one. By approaching Afib with a collaborative approach, individuals with LSPAF in the CONVERGE trial reported better physical and emotional health. For more information and ISI: https://bit.ly/2YxDEyc
Two is better than one. By approaching Afib with a collaborative approach, individuals with LSPAF in the CONVERGE trial reported better physical and emotional health. For more information and ISI: https://bit.ly/2YxDEyc
Cardiovascular diseases, like strokes, are the number 1 cause of death globally. With Afib causing 25% of strokes, it's crucial to treat Afib surgically. Get more data at https://actagainstafib.com #WorldHeartDay
Cardiovascular diseases, like strokes, are the number 1 cause of death globally. With Afib causing 25% of strokes, it's crucial to treat Afib surgically. Get more data at https://actagainstafib.com #WorldHeartDay
social media channels to keep updated on the latest at AtriCure.